SEC Filing Analysis: CHAMPIONS ONCOLOGY, INC. (CSBR)

Executive Summary

• Trading Significance: High
• Key Takeaway: A Director exercised expiring options to acquire shares equivalent to 0.68% of the company's total shares outstanding, increasing his ownership stake to a significant 7.66%.
• Market Impact: Neutral. While not an open-market buy, the decision to exercise expiring options rather than let them lapse is a positive signal of insider conviction. The transaction's size relative to the company's market cap is material.

Company Information

Field	Value
Company	CHAMPIONS ONCOLOGY, INC.
Ticker Symbol	CSBR
CIK	0000771856
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Market Capitalization	$90 million

Insider Information

Field	Value
Name	ACKERMAN JOEL
CIK	0001220630
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-30
Transaction Code	M (Exercise of derivative security)
Security Type	Common Stock
Shares Involved	94,405
Price Per Share	$2.10
Total Value	$198,250.50
Shares Owned After	1,056,539
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$198,250.50
% of Market Cap	0.22%
Shares Transacted	94,405
% of Shares Outstanding	0.68%
Post-Transaction Ownership	1,056,539 shares (7.66% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For a nano-cap company with a $90 million market cap, a transaction adding 0.68% to the share count is a material event.
• Ownership Concentration: The Director's post-transaction stake of 7.66% is substantial, indicating a strong alignment of interests with shareholders.
• Dilution Impact: The exercise increases the total shares outstanding by 0.68%. While a normal part of compensation, this level of dilution is notable for a company of this size.
• Transaction Significance: The transaction is rated 'Highly Significant' because the number of shares involved exceeds the 0.5% threshold of total shares outstanding. This is a meaningful change in the company's ownership structure.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is an option exercise, not an open-market purchase, which carries less weight as a bullish signal. However, the action was taken just before the options were set to expire, suggesting the insider sees future value in holding the equity.

Volume & Sentiment

• Expected Volume Impact: The filing may lead to a minor increase in trading interest due to its high significance rating relative to the company's small size.
• Sentiment Indicator: Neutral. The exercise is procedural due to the expiration date, but it reinforces a significant insider holding, which can be viewed positively by the market.

Investment Insights

Positive Market Indicators

• The Director now holds a substantial 7.66% stake, demonstrating significant 'skin in the game'.
• The decision to exercise rather than let valuable options expire suggests confidence in the company's long-term prospects.

Risk Factors

• The primary driver for the transaction was the imminent expiration of the options, not necessarily a spontaneous belief that the stock is undervalued at the current moment.
• The exercise introduces a 0.68% dilution to existing shareholders.

Key Takeaways

1. A key insider has solidified a large ownership position, now holding 7.66% of the company.
2. The transaction is highly material based on the percentage of shares outstanding, making it a notable event for a nano-cap stock.
3. The timing was driven by the options' expiration date, which provides important context for the insider's action.

Additional Context

Transaction Notes

• Timing: The options were exercised on October 30, 2025, just two days before their expiration date of November 1, 2025.
• Special Circumstances: The options were originally granted in 2016, meaning this was a long-held derivative security.